Patents by Inventor Chuang Sun

Chuang Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240166610
    Abstract: Substituted pyridazine phenol derivatives and a preparation method therefor, specifically relating to a compound as shown in formula (VI) and a pharmaceutically acceptable salt thereof, which can be used as an NLRP3 inhibitor.
    Type: Application
    Filed: January 29, 2022
    Publication date: May 23, 2024
    Inventors: Lingyun WU, Lele ZHAO, Jianjun SUN, Chuang QIAO, Shuhui CHEN
  • Publication number: 20240156864
    Abstract: The present invention provides chimeric antigen receptors (CAR) and methods of use in the treatment of diseases and disorders.
    Type: Application
    Filed: October 30, 2020
    Publication date: May 16, 2024
    Inventors: Gianpietro Dotti, Chuang Sun, Peishun Shou, Yang Xu
  • Publication number: 20240119113
    Abstract: A fault detection method for a rotating machine based on sparse time synchronous averaging is disclosed, and the method includes: collecting a vibration signal and a rotating frequency or rotating frequency pulse signal of the rotating machine and performing analog-to-digital conversion to obtain the vibration signal and rotating speed information by a sensor; according to the type and number of detection components in the rotating machine, constructing a component-aware comb vector g based on the vibration signal and rotating speed information, wherein the type includes the gear, rotor and bearing; constructing a quasi-time synchronous average vector w based on the component-aware comb vector g; constructing a sparse time synchronous averaging model F by using the quasi-time synchronous average vector w; solving the sparse time synchronous averaging model F with an optimization solution algorithm to obtain a sparse spectrum and a reconstruction time signal.
    Type: Application
    Filed: May 5, 2023
    Publication date: April 11, 2024
    Inventors: Shibin WANG, Jianghan ZHOU, Xuefeng CHEN, Zhibin ZHAO, Baoqing DING, Chuang SUN
  • Publication number: 20240014070
    Abstract: Embodiments provide a contact structure and a fabricating method. The method includes: forming an insulating dielectric layer on a substrate; forming a contact hole penetrating through the insulating dielectric layer, where the contact hole includes a first hole segment and a second hole segment communicating with each other, the first hole segment penetrates to the substrate, the second hole segment is positioned on a side of the first hole segment away from the substrate, the first hole segment has a first orthogonal projection on the substrate, the second hole segment has a second orthogonal projection on the substrate, and the second orthographic projection is positioned in the first orthographic projection; and forming a conductive plug in the contact hole.
    Type: Application
    Filed: January 8, 2023
    Publication date: January 11, 2024
    Inventors: Chuang SUN, Dandan HE
  • Publication number: 20230357355
    Abstract: Related are a CSPG4-targeting humanized chimeric antigen receptor and applications thereof, comprising a humanized anti-CSPG4 binding domain, a hinge region, a transmembrane domain, and a signal transduction domain. The anti-CSPG4 binding domain comprises an anti-CSPG4 antibody or antigen binding part. Related are an immune effector cell expressing the CSPG4-targeting humanized chimeric antigen receptor and applications of the cell.
    Type: Application
    Filed: September 23, 2021
    Publication date: November 9, 2023
    Applicant: BOYUAN RUNSHENG PHARMA (HANGZHOU) CO., LTD.
    Inventors: Chuang SUN, Xin-Hua FENG, Bin ZHAO
  • Publication number: 20230055426
    Abstract: Provided are a chimeric antigen receptor capable of targeting B7-H3, a nucleic acid molecule encoding the chimeric antigen receptor, a nucleic acid construct comprising the nucleic acid molecule, an immune effector cell expressing the chimeric antigen receptor, and use thereof. The chimeric antigen receptor comprises an anti-B7-H3 binding domain, a hinge region, a transmembrane domain and a signal transduction domain. Further provided are a composition and a method for diagnosing, treating or preventing tumors that express B7-H3.
    Type: Application
    Filed: August 6, 2020
    Publication date: February 23, 2023
    Inventors: Chuang Sun, Xin-Hua Feng, Bin Zhao